Lung Damage Prevention of Ethanolic Extract of Propolis and Synbiotics in Inhalation Anthrax Model

Wisnu Sanjaya, Dhani Redhono Harioputro, Yulyani Werdiningsih

Abstract

Introduction: Inflammatory response and oxidative stress can be found in inhalation anthrax characterized by the increased level of serum Tumor Necrosis Factor Alpha (TNF-α) and Malondialdehyde (MDA). Ethanolic Extract of Propolis (EEP) and synbiotics were known to have anti-inflammatory and antioxidant properties. This study aimed to determine the effects of EEP and synbiotics on the level of TNF-α and MDA in inhalation anthrax model.

Methods: This was an experimental study with post-test only control group design on 40 samples of Rattus norvegicus with inhalation anthrax. Samples were randomized into 5 groups: control (K), antibiotic and EEP (P1), antibiotic and synbiotic (P2), EEP (P3), and synbiotics(P4). The value of TNF-α and MDA were measured 7 days after the spore’s inhalation and 14th day since the given treatment. To compare the effects of EEP and synbiotics, we used the two-way ANOVA continued by the LSD post-hoc test (if the data normally distributed) or the Kruskal Wallis continued by the Mann Whitney test (if the data not normally distributed).

Results: EEP and synbiotics significantly reduced the level of TNF-α and MDA compared to control group. P2 showed the highest changes on TNF-α and MDA, which TNF-α was decreasing from 14.2825 ± 0.41623 to 8.4363 ± 0.44938 pg/ml and MDA changed from 14.2825 ± 0.41623 to 2.9638 ± 0.39885 nmol/ml. Followed by P4, P1, and P3 groups.

Conclusion: EEP and synbiotics have significant impacts on reducing TNF-α and MDA in model of inhalational anthrax.

Keywords

anthrax; ethanolic extract of propolis; synbiotics; TNF-α; MDA

Full Text:

PDF

References

1. Yu D, He J, Zhang E, Wang P, Liu D, Hou Y, et al. Investigation and source-tracing of an anthrax outbreak in Gansu Province, China. PLoS ONE. 2018;13(8):1–9.

2. Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. Anthrax infection. Am J Respir Crit Care Med. 2011;184(12):1333–1341.

3. Olmos G, Lladó J. Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014;2014:861231.

4. Lorente L, Martín M, Abreu-González P, Domínguez-Rodriguez A, Labarta L, Díaz C. Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients. Crit Care. 2013;17(6):R290.

5. Pasupuleti V, Sammugam L, Ramesh N, Gan S. Honey, propolis, and royal jelly: A comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev. 2017;2017:1259510.

6. Zhao L, Pu L, Wei J, Li J, Wu J, Xin Z, et al. Brazilian green propolis improves antioxidant function in patients with type 2 diabetes mellitus. Int J Environ Res Public Health. 2016;13(5):498.

7. Prasetyo D, Sarsono, Nurwati I, Putranto R, Martini, Prasetyo N. Hepatoprotective and antifibrotic effects of Indonesian Propolis. Majalah Kedokteran Bandung. 2019:51(3):134-140.

8. Swanson KS, Gibson GR, Hutkins R. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 2020;17:687–701.

9. Chundakkattumalayil HC, Kumar S, Narayanan R, Keerthi TR. Role of L. plantarum KX519413 as probiotics and acacia gum as prebiotics in gastrointestinal tract strengthening. Microorganisms. 2019;7(12):659.

10. Salehi-Abargouei A, Ghiasvand R, Hariri M. Prebiotics, prosynbiotics and synbiotics: Can they reduce plasma oxidative stress parameters? A systematic review. Probiotics Antimicrob Proteins. 2017;9(1):1-11.

11. Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: Production, metabolism and signaling mechanism of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;112:21-28.

12. Cherian DA, Peter T, Narayanan A, Madhavan SS, Achammada S, Vynat GP. Malondialdehyde as a marker of oxidative stress in periodontitis patients. J Pharm Bioallied Sci. 2019:11(Suppl 2):S297–S300.

13. Hori JI, Zamboni DS, Carrão DB, Goldman GH, Berretta AA. The inhibition of inflammasome by Brazilian Propolis (EPP-AF). Evid Based Complement Alternat Med. 2013;2013:418508.

14. Pahlavani N, Malekahmadi M, Firouzi S. Molecular and cellular mechanisms of the effects of Propolis in inflammation, oxidative stress and glycemic control in chronic diseases. Nutr Metab (Lond). 2020:17:65.

15. Zheng HJ, Guo J, Jia Q, Huang YS, Huang WJ, Zhang W, et al. The effect of probiotics and synbiotics supplementation on biomarkers of inflammation and oxidative stress in diabetic patients: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2019;142:303-313.

16. Kusumawardani A, Kariosentono H, Purwanto B, Redhono D, Arief RC, Wasita B, et al. The effect of ethanolic extract of Propolis on skin manifestation and skin tissue necrosis in cutaneous anthrax animal model. Sys Rev Pharm. 2020;11(11):1539-1544.

17. Redhono D, Purwanto B, Wasita B, Indarto D, Adji RS, Kusumawardani A, et al. The antioxidant effect of Indonesian Propolis in rats induced by anthrax spores. Sys Rev Pharm. 2021;12(1):557-562.

18. Miryan M, Alavinejad P, Abbaspour M. Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial. Trials. 2020:21:698.

19. McLoughlin RF, Berthon BS, Jensen ME, Baines KJ, Wood LG. Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: A systematic review and meta-analysis. Am J Clin Nutr. 2017;106(3):930-945.

20. María Remes Troche J, Coss Adame E, Ángel Valdovinos Díaz M, Gómez Escudero O, Eugenia Icaza Chávez M, Antonio Chávez-Barrera J, et al. Lactobacillus acidophilus LB: A useful pharmabiotic for the treatment of digestive disorders. Therap Adv Gastroenterol. 2020;13:1756284820971201.

21. Javadi L, Khoshbaten M, Safaiyan A, Ghavami M, Abbasi MM, Gargari BP. Pro- and prebiotics effects on oxidative stress and inflammatory markers in non-alcoholic fatty liver disease. Asia Pac J Clin Nutr. 2018;27(5):1031-1039.

22. Neut C, Mahieux S, Dubreuil LJ. Antibiotic susceptibility of probiotics strains: Is it reasonable to combine probiotics with antibiotics? Médecine et Maladies Infectieuses. 2017;47(7):477–483.

23. Guzmán EL, Cruz FJM. Combinations of Extracts of Propolis and Other Compounds Against Methicillin-Resistant Staphylococcus aureus. Active Ingredients from Aromatic and Medicinal Plants. 2017.

24. Yangi B, Cengiz Ustuner M, Dincer M, Ozbayer C, Tekin N, Ustuner D, et al. Propolis protects endotoxin induced acute lung and liver inflammation through attenuating inflammatory responses and oxidative stress. J Med Food. 2018;21(11):1096-1105.

25. Pei C, Wu Y, Wang X, Wang F, Liu L. Effect of probiotics, prebiotics and synbiotics for chronic bronchitis or chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020;99(45):e23045.

DOI: https://doi.org/10.20961/tscm.v1i1.55203

Refbacks

  • There are currently no refbacks.